LISHAI CREAR: Open Payments
NPI 1134840911 · GALLOWAY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 19 payments from 11 companies in 2025. Trend: 2023 $819 · 2024 $633 · 2025 $742
Food & beverage: $742
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 2 | $153 |
| Novartis Pharmaceuticals Corporation | 2 | $142 |
| AstraZeneca Pharmaceuticals LP | 3 | $116 |
| Novo Nordisk Inc | 1 | $108 |
| Boston Scientific Corporation | 1 | $57 |
| PFIZER INC. | 3 | $51 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $35 |
| Amgen Inc. | 2 | $31 |
| HEARTFLOW, INC. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: Attruby, LEQVIO, Ozempic, ENROUTE Transcarotid Stent, LifeVest, Repatha, FFRct, VYNDAQEL.
Industry payments across NJ — which companies pay providers there.
